Evidilya, the Evidence Generation CRO acting worldwide in the Pharmaceutical and CHC field, has been awarded with the Crédit d’Impôt Recherche (CIR) from the French ministère de l’Enseignement supérieur
This Research Tax accreditation, is a powerful incentive for research partnerships, as all expenditure contracted out to public sector bodies.
Competing at global level in Clinical and RWE solutions, this is unleashing further R&D opportunities working with Evidilya.